AstraZeneca vaccine gives limited protection against South African strain
Share article:
Share article:

AstraZeneca vaccine gives limited protection against South African strain

Credit: Belga

The AstraZeneca vaccine provides only limited protection against the South African variant of the coronavirus, the Financial Times reported on Saturday, based on the provisional results of a study to be released on Monday.

The study was conducted among 2,000 people and still needs to undergo peer reviews.

A spokesperson for AstraZeneca said it was still unclear whether the vaccine provides protection against severe forms of the illness caused by the South African variant (B.1.351) that require hospitalisation since the participants in the study were young and in good health.

However, the pharmaceutical company said it was convinced its vaccine provides protection against the worst forms of the South African variant since it produces antibodies similar to those of other vaccines that are effective against the virus.

It stressed that the vaccine should be effective if the gap of eight to 12 weeks between the two doses is respected.

AstraZeneca and Oxford University are currently working on adapting their vaccine to the B.1.351 variant, and stress that a new, effective vaccine against Covid-19 could be rolled out by autumn.

The Brussels Times

Latest news

Fake PCR tests lead to court hearings for 160 air passengers
In recent months a high number of passengers arriving at Brussels Airport have been found to have fake negative PCR tests; 160 travellers will appear ...
No crowds, limited events: these measures take effect today
Most of Belgium's latest measures already took effect on Saturday, but some changes – concerning public events, sports competitions and schools – ...
Brussels and Liège residents invited to sleep rough to raise awareness for homeless
As temperatures dip below freezing, sleeping on the streets becomes potentially life-threatening, even without factoring in the myriad other hazards ...
Belgium in Brief: Delta, Gamma… Omicron?
Since June, the World Health Organisation (WHO) is no longer calling newly-discovered coronavirus "variants of concern" after the country where they ...
Omicron variant poses ‘very high’ global risk, warns WHO
The Omicron coronavirus variant poses a "very high" global risk for which countries must be well-prepared, said the World Health Organisation (WHO) ...
De Croo: ‘The one certainty that we can rely on is the impact of our personal behaviour’
On Monday morning, Prime Minister Alexander De Croo spoke on La Première radio station about the recently-announced coronavirus measures and, in ...
Booster vaccines already available for all Brussels residents
All residents of the Brussels-Capital Region from 18 years old can make an appointment for a third/booster dose against the coronavirus from this ...
Covid-19 decisions made ‘too hastily’, socialist leader argues
The government is missing a "general lack of method" when it comes to how coronavirus fighting measures are decided on, according to the leader of ...
Aggression against railway staff more than doubled since 2020
In the first three quarters of 2021, the number of reports of aggression against national railway company SNCB's staff has more than doubled compared ...
Intervention hotline 1722 activated following bad weather warnings
Following bad weather warnings from Belgium's Royal Meteorological Institute of Belgium (RMI), the Federal Public Service (FPS) Home Affairs has ...
Several rush hour train services to be scrapped from Monday
Up to ten peak time trains to and from Brussels will be temporarily cancelled starting from Monday, Belgian railway company SNCB announced this ...
Thousands march in Brussels to raise awareness of violence against women
More than 3,000 people took to the streets of Brussels on Sunday afternoon for a national march to raise awareness of violence against women in ...